Identification of the protease inhibitory domain of Trichinella spiralis novel cystatin (TsCstN)
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The Trichinella spiralis novel cystatin (TsCstN) inhibits cathepsin L (CatL) activity and inflammation of macrophages during lipopolysaccharide (LPS) induction. To identify the protease inhibitory region, this study applied an in silico modeling approach to simulate truncation sites of TsCstN (Ts01), which created four truncated forms, including TsCstNΔ1-39 (Ts02), TsCstNΔ1-71 (Ts03), TsCstNΔ1-20, Δ73-117 (Ts04), and TsCstNΔ1-20, Δ42-117 (Ts05). The superimposition of these truncates modeled with AlphaFold Colab indicated that their structures were more akin to Ts01 than those modeled with I-TASSER. Moreover, Ts04 exhibited the closest resemblance to the structure of Ts01. The recombinant Ts01 (rTs01) and truncated proteins (rTs02, rTs03, and rTs04) were successfully expressed in a prokaryotic expression system while Ts05 was synthesized, with sizes of approximately 14, 12, 8, 10, and 2.5 kDa, respectively. When determining the inhibition of CatL activity, both rTs01 and rTs04 effectively reduced CatL activity in vitro. Thus, the combination of the α1 and L1 regions may be sufficient to inhibit CatL. This study provides comprehensive insights into TsCstN, particularly regarding its protein function and inhibitory domains against CatL.
Abstract
The Trichinella spiralis novel cystatin (TsCstN) inhibits cathepsin L (CatL) activity and inflammation of macrophages during lipopolysaccharide (LPS) induction. To identify the protease inhibitory region, this study applied an in silico modeling approach to simulate truncation sites of TsCstN (Ts01), which created four truncated forms, including TsCstNΔ1-39 (Ts02), TsCstNΔ1-71 (Ts03), TsCstNΔ1-20, Δ73-117 (Ts04), and TsCstNΔ1-20, Δ42-117 (Ts05). The superimposition of these truncates modeled with AlphaFold Colab indicated that their structures were more akin to Ts01 than those modeled with I-TASSER. Moreover, Ts04 exhibited the closest resemblance to the structure of Ts01. The recombinant Ts01 (rTs01) and truncated proteins (rTs02, rTs03, and rTs04) were successfully expressed in a prokaryotic expression system while Ts05 was synthesized, with sizes of approximately 14, 12, 8, 10, and 2.5 kDa, respectively. When determining the inhibition of CatL activity, both rTs01 and rTs04 effectively reduced CatL activity in vitro. Thus, the combination of the α1 and L1 regions may be sufficient to inhibit CatL. This study provides comprehensive insights into TsCstN, particularly regarding its protein function and inhibitory domains against CatL.
참고문헌 (31)
- Murrell KD, "Worldwide occurrence and impact of human trichinellosis, 1986-2009", Emerg Infect Dis, 17(12), pp.2194~2202 (2011)[DOI]
- Despommier DD, "How does Trichinella spiralis make itself at home?", Parasitol Today, 14(8), pp.318~323 (1998)[DOI]
- Fabre MV, "Immunity to Trichinella spiralis muscle infection", Vet Parasitol, 159(3-4), pp.245~248 (2009)[DOI]
- Alvarez JI, "Inhibition of toll like receptor immune responses by microbial pathogens", Front Biosci, 10, pp.582~587 (2005)[DOI]
- Aranzamendi C, "Trichinella spiralis-secreted products modulate DC functionality and expand regulatory T cells in vitro", Parasite Immunol, 34(4), pp.210~223 (2012)[DOI]
- Kobpornchai P, "A novel cystatin derived from Trichinella spiralis suppresses macrophage-mediated inflammatory responses", PLoS Negl Trop Dis, 14(4), pp.e0008192~ (2020)[DOI]
- Kobpornchai P, "Trichinella spiralis cystatin, TsCstN, modulates STAT4", IL-12 to specifically suppress IFN-γ production, 2021, pp.362, 104303~
- Khatri V, "Peptide fragments of cystatin protein from filarial parasite has potent anti-inflammatory effect on DSS-induced colitis in mouse", J Immunol, 204(Suppl), pp.237.28~ (2020)[DOI]
- Pikuła M, "Cystatin C peptidomimetic derivative with antimicrobial properties as a potential compound against wound infections", Bioorg Med Chem, 25(4), pp.1431~1439 (2017)[DOI]
- Hill M, "Cystatin C peptide effects on B16F10 melanoma cells", CellBio, 10, pp.1~9 (2021)[DOI]
- Larkin MA, "Clustal W and Clustal X version 2. 0", Bioinformatics, 23(21), pp.2947~2948 (2007)[DOI]
- McGuffin LJ, "The PSIPRED protein structure prediction server", Bioinformatics, 16(4), pp.404~405 (2000)[DOI]
- Drozdetskiy A, "JPred4 : a protein secondary structure prediction server", Nucleic Acids Res, 43(W1), pp.W389~W394 (2015)[DOI]
- Rost B, "Prediction of protein secondary structure at better than 70% accuracy", J Mol Biol, 232(2), pp.584~599 (1993)[DOI]
- Kelley LA, "The Phyre2 web portal for protein modeling, prediction and analysis", Nat Protoc, 10(6), pp.845~858 (2015)[DOI]
- Hall TA, "Bioedit : a user-friendly biological sequence alignment editor and analysis program for windows 95", 98, Nucleic Acid Symposium Series, pp.1999, 41[DOI]
- Yang J, "The I-TASSER Suite : protein structure and function prediction", Nat Methods, 12(1), pp.7~8 (2015)[DOI]
- Jumper J, "Highly accurate protein structure prediction with AlphaFold", Nature, 596(7873), pp.583~589 (2021)[DOI]
- Laskowski RA, "PROCHECK : a program to check the stereochemical quality of protein structures", J Appl Crystallogr, 26(2), pp.283~291 (1993)[DOI]
- Waterhouse A, "SWISS-MODEL : homology modelling of protein structures and complexes", Nucleic Acids Res, 46(W1), pp.296~303 (2018)[DOI]
- Khatri V, "Parasite cystatin : immunomodulatory molecule with therapeutic activity against immune mediated disorders", Pathogens, 9(6), pp.431~ (2020)[DOI]
- Beard DK, "Crystal structure of a hypothetical protein from Giardia lamblia. Corrigendum", Acta Crystallogr F Struct Biol Commun, 78(3), pp.143~ (2022)[DOI]
- Arakaki T, "Structure of Lmaj006129AAA, a hypothetical protein from Leishmania major", Acta Crystallogr Sect F Struct Biol Cryst Commun, 62(3), pp.175~179 (2006)[DOI]
- Masamba P, "Crystallization and preliminary structural determination of the universal stress G4LZI3protein from Schistosoma mansoni", Inform Med Unlocked, 32, pp.101057~ (2022)[DOI]
- Yang Z, "AlphaFold2 and its applications in the fields of biology and medicine", Signal Transduct Target Ther, 8(1), pp.115~ (2023)[DOI]
- Ros-Lucas A, "The use of AlphaFold for in silico exploration of drug targets in the parasite Trypanosoma cruzi", Front Cell Infect Microbiol, 12, pp.944748~ (2022)[DOI]
- Pak MA, "Using AlphaFold to predict the impact of single mutations on protein stability and function", PLoS One, 18(3), pp.e0282689~ (2023)[DOI]
- Honey K, "Lysosomal cysteine proteases regulate antigen presentation", Nat Rev Immunol, 3(6), pp.472~482 (2003)[DOI]
- Zhang T, "Lysosomal cathepsin B plays an important role in antigen processing, while cathepsin D is involved in degradation of the invariant chain inovalbumin-immunized mice", Immunology, 100(1), pp.13~20 (2000)[DOI]
- Salát J, "Crystal structure and functional characterization of an immunomodulatory salivary cystatin from the soft tick Ornithodoros moubata", Biochem J, 429(1), pp.103~112 (2010)[DOI]
- Shibuya K, "Human cystatin A is inactivated by engineered truncation. The NH2-terminal region of the cysteine proteinase inhibitor is essential for expression of its inhibitory activity", Biochemistry, 34(38), pp.12185~12192 (1995)[DOI]